photo of

Details

Role Team Leader / Senior Research Officer
Research area Stem Cell Medicine

Contact

Available for student supervision
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. ...
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.

Top Publications

  • McNamara, JW, Schuckman, M, Becker, RC, Sadayappan, S. A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy.. Front Physiol 11: 608473 2020
    view publication
  • Li, A, Nelson, SR, Rahmanseresht, S, Braet, F, Cornachione, AS, Previs, SB, O'Leary, TS, McNamara, JW, Rassier, DE, Sadayappan, S, et al. Skeletal MyBP-C isoforms tune the molecular contractility of divergent skeletal muscle systems.. Proc Natl Acad Sci U S A 116(43) : 21882 -21892 2019
    view publication
  • Ge, Z, Li, A, McNamara, J, dos Remedios, C, Lal, S. Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies. Heart Failure Reviews 24(5) : 743 -758 2019
    view publication
  • Singh, RR, McNamara, JW, Sadayappan, S. Abstract 915: Dysregulation of the Myosin and Myosin Binding Protein-C interaction in Hypertrophic Cardiomyopathy. Circulation Research 125(Suppl_1) : 2019
    view publication
  • McNamara, JW, Schwanekamp, JA, Patel, PN, Viswanathan, SK, Bohlooly, M, Madeyski-Bengtson, K, Knöll, R, Seidman, JG, Seidman, CE, Sadayappan, S. Abstract 772: The Highly Prevalent 25bp Intronic Deletion in MYBPC3 is Benign Under Baseline Conditions. Circulation Research 125(Suppl_1) : 2019
    view publication

Page 4 of 8